The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27: An in vitro experiment

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 11, 2008, Pages 1528-1532

  Verdegaal, S H M ^a   Corver, W E ^a   Hogendoorn, P C W ^a   Taminiau, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PHENOL;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN OUMS 27; CHONDROSARCOMA; CONCENTRATION RESPONSE; CURETTAGE; DRUG CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

CELL LINE; CHEMOTHERAPY, ADJUVANT; CHONDROSARCOMA; CURETTAGE; CYTOTOXINS; ETHANOL; HUMANS; PHENOL; STATISTICS AS TOPIC;

EID: 55549112558     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B11.21029     Document Type: Article

References (19)

1. Huvos AG. Chondrosarcoma, including spindle-cell (dedifferentiated) and myxoid chondrosarcoma: mesenchymal chondrosarcoma. In: Bone tumors: diagnosis, treatment and prognosis. Second ed. Philadelphia: W. B. Saunders Company, 1991:343-93.
2. Bovée JVMG, Cleton-Jansen AM, Kuipers-Dijkshoorn NJ, et al. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosones Cancer 1999;26:237-46.
3. Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology & Genetics: Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002:247-51.
4. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathological analysis with emphasis on histologic grading. Cancer 1977;40:818-31.
5. Bovée JVMG, Hogendoorn PCW. Cartilage-forming tumours of bone and soft tissue and their differential diagnosis. Current Diagnostic Pathology 2001;7:223-34.
6. Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 2000;11:627-38.
7. Bovée JVMG, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 2005;6:599-607.
8. Donati D, El Ghoneimy A, Bertoni F, Di Bella C, Mecuri M. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg [Br] 2005;87-B:1527-30.
9. Persson BM, Wouters HM. Curettage and acrylic cementation in surgical treatment of giant cell tumor of bone. Clin Orthop 1976;120:125-33.
10. Malawer MM, Marks MR, McChesney D, et al. The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects. Clin Orthop 1988;226:299-310.
11. Veth RPH, Schreuder HWB, Beem van H, Pruszczynski M, Rooy de J. Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol 2005;6:25-34.
12. Marcove RC, Stovell PB, Huvos AG, Bullough PG. The use of cryosurgery in the treatment of low and medium grade chondrosarcoma: a preliminary report. Clin Orthop 1977;122:147-56.
13. Schreuder HWB, Keijser LC, Veth RPH. Beneficial effects of cryosurgical treatment: benign and low-grade malignant bone tumors in 120 patients. Ned Tijdschr Geneeskd 1999;143:2275-81 (in Dutch).
14. Lang S, Lack W, Brand G, Salzer-Kuntschik M. Devitalizing effects of phenol on bone marrow cells: histological study on cadaveric animal vertebrae. Acta Orthop Scand 1991;62:383-5.
15. Lack W, Lang S, Brand G. Necrotizing effect of phenol on normal tissues and on tumors: a study on postoperative and cadaver specimens. Acta Orthop Scand 1994;65:351-4.
16. Kunisada T, Miyazaki M, Mihara K, et al. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 1998;77:854-9.
17. Friedl F, Kimura I, Osato T, Ito Y. Studies on a new human cell (SiHa) derived from carcinoma of uterus. I: Its establishment and morphology. Proc Soc Exp Biol Med 1970;135:543-5.
18. Corver WE, Cornelisse CJ, Hermans J, Fleuren GJ. Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation. Cytometry 1995;19:267-72.
19. Sasaki DT, Dumas SE, Engelman EG. Discrimination of viable and non-viable cells using propidium iodide in two colour immunofluorescence. Cytometry 1987;8:413-20.